Ceva acquires French vaccine manufacturer

Acquisition of autogenous vaccine maker Biovac will reinforce Ceva's strategy to find alternative solutions to antibiotics.

Ceva Sante Animale announced the purchase of Biovac Laboratories, a leading manufacturer of autogenous (bacterial) vaccines, allergy treatments and reagents based in Angers, France.

Biovac, like Ceva, has experienced double-digit growth for several years as veterinarians seek alternatives to control bacterial conditions that are often difficult to treat with "classic" antibiotherapy. The company has significant expertise in microbiology, allowing it to provide custom-made solutions

All access premium subscription

This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.

Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)

Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit Feedstuffs.com and click on Subscribe at the top of the page for more information.

SUBSCRIBE NOW https://circulation.feedstuffs.com/Publications.aspx

TO RENEW YOUR SUBSCRIPTION https://circulation.feedstuffs.com/SubscriptionOffers.aspx

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.